1. Home
  2. HFFG vs ADVM Comparison

HFFG vs ADVM Comparison

Compare HFFG & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HFFG
  • ADVM
  • Stock Information
  • Founded
  • HFFG 1997
  • ADVM 2006
  • Country
  • HFFG United States
  • ADVM United States
  • Employees
  • HFFG N/A
  • ADVM N/A
  • Industry
  • HFFG Food Distributors
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • HFFG Consumer Discretionary
  • ADVM Health Care
  • Exchange
  • HFFG Nasdaq
  • ADVM Nasdaq
  • Market Cap
  • HFFG 100.2M
  • ADVM 98.0M
  • IPO Year
  • HFFG N/A
  • ADVM 2014
  • Fundamental
  • Price
  • HFFG $3.92
  • ADVM $2.93
  • Analyst Decision
  • HFFG
  • ADVM Strong Buy
  • Analyst Count
  • HFFG 0
  • ADVM 6
  • Target Price
  • HFFG N/A
  • ADVM $25.83
  • AVG Volume (30 Days)
  • HFFG 320.9K
  • ADVM 176.5K
  • Earning Date
  • HFFG 05-07-2025
  • ADVM 04-15-2025
  • Dividend Yield
  • HFFG N/A
  • ADVM N/A
  • EPS Growth
  • HFFG N/A
  • ADVM N/A
  • EPS
  • HFFG N/A
  • ADVM N/A
  • Revenue
  • HFFG $1,201,667,000.00
  • ADVM $1,000,000.00
  • Revenue This Year
  • HFFG $4.77
  • ADVM $1,187.80
  • Revenue Next Year
  • HFFG $3.97
  • ADVM N/A
  • P/E Ratio
  • HFFG N/A
  • ADVM N/A
  • Revenue Growth
  • HFFG 4.63
  • ADVM N/A
  • 52 Week Low
  • HFFG $1.70
  • ADVM $2.89
  • 52 Week High
  • HFFG $4.93
  • ADVM $11.87
  • Technical
  • Relative Strength Index (RSI)
  • HFFG 53.69
  • ADVM 31.79
  • Support Level
  • HFFG $3.87
  • ADVM $3.07
  • Resistance Level
  • HFFG $4.18
  • ADVM $3.71
  • Average True Range (ATR)
  • HFFG 0.43
  • ADVM 0.46
  • MACD
  • HFFG -0.11
  • ADVM -0.12
  • Stochastic Oscillator
  • HFFG 17.89
  • ADVM 9.20

About HFFG HF Foods Group Inc.

HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The Company's business consists of one operating segment; HF Group, which operates solely in the United States. The Company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections. It has one segment developing and commercializing gene therapeutics.

Share on Social Networks: